In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease
The recent coronavirus disease (COVID-19) outbreak in Wuhan, China, has led to millions of infections and the death of approximately one million people. No targeted therapeutics are currently available, and only a few efficient treatment options are accessible. Many researchers are investigating act...
Main Authors: | Piyush Kashyap, Mamta Thakur, Nidhi Singh, Deep Shikha, Shiv Kumar, Poonam Baniwal, Yogender Singh Yadav, Minaxi Sharma, Kandi Sridhar, Baskaran Stephen Inbaraj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/19/6374 |
Similar Items
-
Anticoagulants as Potential SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
by: Ayman Abo Elmaaty, et al.
Published: (2022-10-01) -
In Silico and In Vitro Inhibition of SARS-CoV-2 PL<sup>pro</sup> with Gramicidin D
by: Sara Protić, et al.
Published: (2023-01-01) -
Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt
by: Ragaey A. Eid, et al.
Published: (2021-10-01) -
Chemical Composition of the Red Sea Green Algae <i>Ulva lactuca</i>: Isolation and In Silico Studies of New Anti-COVID-19 Ceramides
by: Enas E. Eltamany, et al.
Published: (2021-11-01) -
Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 M<sup>Pro</sup> Inhibitor
by: Hani A. Alhadrami, et al.
Published: (2021-06-01)